Page last updated: 2024-11-01

masoprocol and Methemoglobinemia

masoprocol has been researched along with Methemoglobinemia in 1 studies

nordihydroguaretic acid: antioxidant compound found in the creosote bush (Larrea tridentata)

Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruneau, P1
Delvare, C1
Edwards, MP1
McMillan, RM1

Other Studies

1 other study available for masoprocol and Methemoglobinemia

ArticleYear
Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:3

    Topics: Administration, Oral; Animals; Chemical Phenomena; Chemistry; Dinoprostone; Dogs; Humans; Indazoles;

1991